MENU

Sanjay S. Reddy, MD, FACS

Dr. Sanjay Reddy

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

About

Assistant Professor, Department of Surgical Oncology

Attending Surgeon

TRDG Member, Esophagus, Pancreas, and Liver CancerMelanoma and Skin CancerSarcoma and GIST Cancer

Treatment Focus

Hyperthermic intraperitoneal chemotherapy (HIPEC), gastric cancer, hepatobiliary cancer, general and minimally invasive surgery

Treatment Philosophy

I decided to join the Fox Chase Cancer Center team in conquering cancer because I saw first-hand the dramatic difference we can make here. I decided to continue my training in Philadelphia after completing my general surgery residency in New York City, under the tutelage of my father, also a surgeon who spent many years treating cancer. I completed a two-year fellowship in complex surgical oncology at Fox Chase, working closely with various multidisciplinary teams in caring for patients with colorectal, liver, pancreatic and stomach cancers, in addition to melanoma and sarcomas. Being trained by leaders in the field, I had the unique opportunity to hone my skills and expertise, and apply them to my own clinical practice.

I have extensive training in traditional open surgery, as well as laparoscopic and robotic techniques, allowing me to offer individualized care to patients. I have particular interests in the management of sarcomas and colorectal, melanoma and pancreatic cancers. The implementation of minimally-invasive surgical techniques to the management of colorectal cancer is routinely offered at Fox Chase, and similar techniques are used to address pancreatic diseases. I also have a keen interest in the use of hyperthermic intraperitoneal chemotherapy (HIPEC), following cytoreductive surgery for cancer of the peritoneum, including appendix cancer, peritoneal mesothelioma and pseudomyxoma peritonei. In addition to this, there is a necessity to understand the benefit of, and perform further research, incorporating HIPEC in patients with colorectal and gastric cancers, which our team will explore further.

The benefit of an NCI-designated cancer center is that we are able to offer many innovative strategies in treating all types of cancers. Whether through a national clinical trial or particular surgical technique, we optimize patient care to the individual. I believe the physician-patient relationship is one of the foundations to building a plan to treat cancer, and I offer guidance through each stage of treatment. Medicine has always been a family-oriented field for me; with my father being a surgeon, and mother an anesthesiologist, I take great pride in offering compassion and honesty in formulating individualized treatment plans for every patient and his or her family.

Follow on Twitter: @FCCCSurgOnc

Education and Training

Educational Background

  • Fellowship, Surgical Oncology Fellow, Fox Chase Cancer Center, Temple University Hospital, Philadelphia, PA
  • Residency, General Surgery, Beth Israel Medical Center, New York, NY

Certifications

  • Complex Surgical Oncology, 2014
  • American Board of Surgery, 2012
  • Board Certified in Complex Surgical Oncology

Memberships

  • American College of Surgeons
  • Clinical Robotics Surgical Association
  • Association for Academic Surgery
  • American Society of Clinical Oncology
  • Society of Surgical Oncology
  • Society for Surgery of the Alimentary Tract
  • Pancreas Club
  • American Cancer Society- Metropolitan Philadelphia Chapter

Honors & Awards

  • The John (Drew) Ridge Fellowship Award in Surgical Oncology, 2014
  • Resident Teaching Award, Beth Israel Medical Center, Albert Einstein College of Medicine,2011
  • Resident Teaching Award, St. Vincent's Medical Center, New York Medical College, 2010
  • Harriet Gold Foundation, Scholar in Humanism Award, New York Medical College, 2010
  • Academic Achievement in Molecular Cell Biology, St. Vincent's Medical Center, New York, NY, 2009
  • Pi Kappa Alpha, Honors Society, 2002-2003
  • University of Connecticut Dean's List, 2002-2003
Patient Stories

Judith Ingraham

Sarcoma

Judith Ingraham

Sarcoma

Judith Ingraham was diagnosed with synovial soft tissue sarcoma at the age of 58 when she sought a second opinion on a small lump she noticed on the lower part of her left leg. She was referred to Fox Chase Cancer Center for further treatment, where she underwent surgery to remove the cancer as well as reconstructive surgery, followed by radiation therapy. Today she is cancer free and feeling well. "I recommend Fox Chase to anyone who needs great care," Judith said. "I am so happy I was referred to Fox Chase where I have been blessed with my doctors and all of the Fox Chase employees I have met during this journey."

Irene Cohen

Breast Cancer;  Colorectal Cancer

Irene Cohen

Breast Cancer;  Colorectal Cancer

I was 50 years old in 2002 when a routine mammogram detected a mass that turned out to be breast cancer. I had a lumpectomy at a community hospital and decided to have follow-up radiation therapy at Fox Chase.

Michael Buzalewski

Stomach Cancer

Michael Buzalewski

Stomach Cancer

After a diagnosis of metastatic adenocarcinoma of unknown primary, Michael Buzalewski decided to seek a second opinion from Dr. Sanjay Reddy at Fox Chase Cancer Center. Michael liked him immediately and felt he was in good hands being in Dr. Reddy's care. Dr. Reddy recommended surgery along with hyperthermic intraperitoneal chemotherapy (HIPEC), an innovative technique that delivers highly concentrated, heated chemotherapy treatment directly to the abdomen during surgery. This technique allows higher doses of chemotherapy to be administered directly to the tumor. "I believe I am here today because of Dr. Reddy and the medical oncologists at Fox Chase," Michael said. "The innovative treatments offered at Fox Chase have enabled me to return to work and continue to do the things I love to do... I will continue my care at Fox Chase because I am living proof that the dedicated team of doctors and nurses helped get me where I am today."

Janet Blair

Breast Cancer

Janet Blair

Breast Cancer

I was 62 years old in January 2014 when a routine mammogram detected a cluster of calcifications in my left breast. Further testing showed that I had stage 3 breast cancer. I was scared and knew I needed to make some decisions.

Helene Mullen

Stomach Cancer

Helene Mullen

Stomach Cancer

When I started experiencing chronic and uncomfortable digestive issues over the course of two years, my primary care doctor prescribed heartburn medication, and I made changes in my diet. During that period, I often had an achy, acidy stomach, and I was taking Tums all the time. When the symptoms continued, my doctor referred me to a gastrointestinal specialist who conducted an endoscopy to examine my digestive tract in 2015.

Pages

Research Profile

Research Interests

My research interest for colorectal malignancies focuses on the use of national cancer databases to assess the accuracy of clinical staging, to see if this has improved over time, and to observe reporting standards between academic institutions versus other centers. As treatment of colorectal cancers involve multimodality planning, accurate clinical staging proves to be the foundation on how best to deliver care.

I also have a strong research interest in the vascular resectability staging of pancreatic cancer. Currently under review is our preoperative venous and arterial staging for borderline resectable pancreatic cancers and whether we are able to predict from preoperative imaging the likelihood of clear margin achievement and prognosis. As treatment of borderline resectable pancreatic cancer continues to evolve, accurate preoperative vascular resectability staging is imperative to assess and guide multimodality therapy.

Publications

Selected Publications

Moten AS, Movva S, von Mehren M, Wu H, Esnaola NF, Reddy SS, Farma JM. Granular cell tumor experience at a comprehensive cancer center. J Surg Res, 226:1-7, 2018. PubMed

Barnica VH, Reddy SS, Wu H, Fang Z, Olszanski A, Farma JM. High Mitotic Rates in Patients with Cutaneous Melanoma. (Manuscript pending publication).

Reddy SS, Cooper HS, Ruth K, Chun YS, Watson JC, Hoffman JP. The Role of Adjuvant Chemoradiotherapy in Pancreatobiliary versus Intestinal Subtypes of Ampullary Cancers. Gastroenterology. Volume 144(5). 1107-1108. (Manuscript pending publication).

Reddy SS, Boukovalas S, Barnica V, Fang Z, Wu H, Farma JM. The Presence of Tumor Infiltrating Lymphocytes and their Role as a Prognostic Indicator for Melanoma. (Manuscript pending publication).

Reddy SS, Hoffman JP. Letter to the Editor Referencing, Kelly et al, Vein Involvement during Pancreaticoduodenectomy: is there a need for Redefinition of “Borderline Resectable Disease?” Journal of Gastrointestinal Surgery. February 2014.

Reddy SS, Leitman IM. Blood Transfusions in the Surgical Patient: A Gift of Life, but at What Cost? J Surg Res. Volume 181 (2): 216-218. May 2013.

Reddy SS, Leitman IM. Pharmacotherapy for Traumatic Spinal Cord Injury: The Science Behind the Promise. J Surg Res. Volume 181(2): 222-224. May 2013.

Reddy SS, Bloom ND. En Bloc Resection of Extra-Peritoneal Soft Tissue Neoplasms Incorporating a Type III Internal Hemipelvectomy: a Novel Approach. World J Surg Oncol. Volume 10(222): 1-6. October 2012.

Wayne MG, Reddy SS, Pacholka J, Yuan S, Levi G. Inflammatory Pseudotumor of the Spleen: Case Report. Journal of Solid Tumors. Volume 2(2): 43-46. April 2012.

Chander RK, Iskander M, Reddy SS, Kigongo S, Ingram M, Madlinger RV.  Laparoscopic Dissection of Para-Aortic Mass. Surgical Science. August 2011.

Martins PN, Reddy SS, Martins AB, Facciuto ME. Follicular Dendritic Cell Sarcoma of the Liver: An Unusual Presentation of a Rare Tumor and Literature Review. Journal of Hepatobiliary Pancreat Dis Int. Volume 10: 443-5. August 2011.

Ratings

121 PATIENT SATISFACTION REVIEWS

Our Patient Satisfaction Rating is an average of all responses to care provider related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more.

OVERALL RATING

4.9 / 5.0

RATINGS BREAKDOWN

  • 4.8
  • 4.8
  • 4.9
  • 5.0
  • 4.8

12 PATIENT COMMENTS

  • 5.0
    September 27, 2018
    Dr. Reddy feels genuinely concerned about you and instills a sense of positivity.
  • 5.0
    September 13, 2018
    Dr Reddy was a pleasure to talk too.. took his time to explain the process in a easy way to understand
  • 5.0
    September 11, 2018
    I can't even begin to explain how grateful I am of this man, who saved my life! He is, hands down, the BEST physician ever!! My family & I absolutely love him!!
  • 5.0
    August 23, 2018
    From the first day I walked through Fox Chase, and received my initial consult with Doctor Sanjay Reddy, I have shared with every, and anyone that they or their loves ones maybe having challenges with Caner, I have referred to Fox Chase Cancer Treatment Center, along with Dr. Reddy, for the remarkable medical and care and treatments.
  • 5.0
    July 19, 2018
    Dr. Reddy & all staff exceptional with patient & family.
  • 4.5
    June 19, 2018
    All good. Dr. Reddy is the best!
  • 5.0
    June 08, 2018
    I was given explanations about things that happened 1 1/2 yrs. ago and why. Excellent! IE., my rash was due to a glue (surgical) allergy! Swelling on my legs due to removed lymph nodes! Non of his info came from my previous doctor. [...]
  • 5.0
    May 24, 2018
    [...] I couldn't be in better hands with Dr ready, Dr [...] and [...].
  • 5.0
    March 29, 2018
    Dr Reddy and his team are excellent. I have and will continue to recommend Fox Chase.
  • 4.5
    March 20, 2018
    terrific!
  • 5.0
    March 19, 2018
    Would reccomend this provider, just hope I never have to.
  • 3.0
    February 07, 2018
    Dr. Reddy is very nice!
LOAD MORE

Connect with Fox Chase